Data di Pubblicazione:
2022
Citazione:
Novel pharmacological therapies for the treatment of endometriosis / L. Buggio, D. Dridi, G. Barbara, C.E.M. Merli, G.E. Cetera, P. Vercellini. - In: EXPERT REVIEW OF CLINICAL PHARMACOLOGY. - ISSN 1751-2433. - 15:9(2022 Aug 30), pp. 1039-1052. [10.1080/17512433.2022.2117155]
Abstract:
Endometriosis is a chronic, estrogen-dependent, inflammatory disease associated with pelvic pain, infertility, impaired sexual function, and psychological suffering. Therefore, tailored patient management appears of primary importance to address specific issues and identify the appropriate treatment for each woman. Over the years, abundant research has been carried out with the objective to find new therapeutic approaches for this multifaceted disease.
Tipologia IRIS:
01 - Articolo su periodico
Keywords:
GnRH antagonist; SERM; SPRM; elagolix; endometriosis; linzagolix; relugolix
Elenco autori:
L. Buggio, D. Dridi, G. Barbara, C.E.M. Merli, G.E. Cetera, P. Vercellini
Link alla scheda completa:
Link al Full Text: